Programmed Cell Death in the Terminal Endbud

Journal of Mammary Gland Biology and Neoplasia

Volumn 4, Issue 2, 1999, Pages 213-220

  Humphreys, Robin C ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Apoptosis; Ductal development; Mammary gland; Terminal endbud

Indexed keywords

PROTEIN BCL 2;

ANIMAL; APOPTOSIS; CELL DIVISION; CYTOLOGY; EPITHELIUM CELL; FEMALE; METABOLISM; MOUSE; PHYSIOLOGY; REVIEW; UDDER;

ANIMALS; APOPTOSIS; CELL DIVISION; EPITHELIAL CELLS; FEMALE; MAMMARY GLANDS, ANIMAL; MICE; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0033113029     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018733426625     Document Type: Article

References (46)

1. A. Glucksmann (1951). Cell death in normal vertebrate ontogeny. Biol. Rev. 26:59-86.
2. J. W. Saunders (1966). Death in embryonic systems. Science 154:604-612.
3. M. D. Jacobson, M. Weil, and M. C. Raff (1997). Programmed cell death in animal development. Cell 88:347-354.
4. H. S. Coles, J. F. Burne, and M. C. Raff (1993). Large-scale normal cell death in the developing rat kidney and its reduction by epidermal growth factor. Development 118:777-784.
5. C. W. Daniel and G. B. Silberstein (1985). In M. Neville and C. Daniel (eds.) The Mammary Gland Development Regulation and Function, Plenum pp. 3-36.
6. R. C. Humphreys, M. Krajewska, S. Krnacik, R. Jaeger, H. Weiher, S. Krajewski, J. C. Reed, and J. M. Rosen (1996). Apoptosis in the terminal endbud of the murine mammary gland: A mechanism of ductal morphogenesis. Development 122:4013-4022.
7. R. Dulbecco, M. Henahan, and B. Armstrong (1982). Cell types and morphogenesis in the mammary gland. Proc. Natl. Acad. Sci. U.S.A. 79:7346-7350.
8. R. Dulbecco, M. Unger, B. Armstrong, M. Bowman, and P. Syka (1983). Epithelial cell types and their evolution in the rat mammary gland determined by immunological markers. Proc. Natl. Acad. Sci. U.S.A. 80:1033-1037.
9. C. H. Knight and M. Peaker (1982). Development of the mammary gland. J. Reprod. Fertil. 65:521-536.
10. D. J. Pierce, M. D. Johnson, Y. Matsui, S. D. Robinson, L. I. Gold, A. F. Purchio, C. W. Daniel, B. L. Hogan, H. L. Moses (1993). Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-beta 1. Genes Dev. 7:2308-2317.
11. G. B. Silberstein, H. K. Van, G. Shyamala, and C. W. Daniel (1994). Essential role of endogenous estrogen in directly stimulating mammary growth demonstrated by implants containing pure antiestrogens. Endocrinology 134:84-90.
12. G. B. Silberstein, P. Strickland, S. Coleman, and C. W. Daniel (1990). Epithelium-dependent extracellular matrix synthesis in transforming growth factor-beta 1-growth-inhibited mouse mammary gland. J. Cell Biol. 110:2209-2219.
13. R. C. Humphreys, J. Lydon, B. W. O'Malley, and J. M. Rosen (1997). Mammary gland development is mediated by both stromal and epithelial progesterone receptors. Mol. Endocrinol. 11:801-811.
14. C. W. Daniel and S. D. Robinson (1992). Regulation of mammary growth and function by TGF-beta. Mol. Repro. Dev. 32:145-151.
15. C. W. Daniel, G. B. Silberstein, and P. Strickland (1987). Direct action of 17 beta-estradiol on mouse mammary ducts analyzed by sustained release implants and steroid autoradiography. Cancer Res. 47:6052-6057.
16. S. Coleman and C. W. Daniel (1990). Inhibition of mouse mammary ductal morphogenesis and down-regulation of the EGF receptor by epidermal growth factor. Dev. Biol. 137: 425-433.
17. W. Ruan, C. B. Newman, D. L. Kleinberg (1992). Intact and amino-terminally shortened forms of insulin-like growth factor I induce mammary gland differentiation and development. Proc. Natl. Acad. Sci. U.S.A. 89:10872-10876.
18. P. D. Walden, W. Ruan, M. Feldman, and D. L. Kleinberg (1998). Evidence that the mammary fat pad mediates the action of growth hormone in mammary gland development. Endocrinology 139:659-662.
19. Y. Gavrieli, Y. Sherman, and S. S. Ben (1992). Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493-501.
20. G. B. Silberstein, K. Van Horn, G. Shyamala, and C. W. Daniel (1996). Progesterone receptors in the mouse mammary duct. Cell Growth Differ. 7:945-952.
21. Z. Feng, A. Marti, B. Jehn, H. J. Altermatt, G. Chicaiza, and R. Jaggi (1995). Glucocorticoid and progesterone inhibit involution and programmed cell death in the mouse mammary gland. J. Cell Biol. 131:1095-1103.
22. D. L. Hadsell, N. M. Greenberg, J. M. Fligger, C. R. Baumrucker, and J. M. Rosen (1996). Targeted expression of des (1-3) human insulin-like growth factor I in transgenic mice influences mammary gland development and IGF-binding protein expression [see comments]. Endocrinology 137: 321-330.
23. S. Coleman, G. B. Silberstein, and C. W. Daniel (1988). Ductal morphogenesis in the mouse mammary gland: Evidence supporting a role for epidermal growth factor. Dev. Biol. 127: 304-315.
24. W. Imagawa, Y. Tomooka, S. Hamamoto, and S. Nandi (1985). Stimulation of mammary epithelial cell growth in vitro: Interaction of epidermal growth factor and mammogenic hormones. Endocrinology 116:1514-1524.
25. G. R. Merlo, F. Basolo, L. Fiore, L. Duboc, and N. E. Hynes (1995). p53-dependent and p53-independent activation of apoptosis in mammary. J. Cell Biol. 128:1185-1196.
26. T. M. Casey, H. Chen, K. Plaut, and J. F. Chiu (1996). Involution of mouse mammary glands during whole organ culture occurs. Cell. Biol. Int. 20:763-767.
27. G. B. Silberstein, K. C. Flanders, A. B. Roberts, and C. W. Daniel (1992). Regulation of mammary morphogenesis: Evidence for extracellular matrix-mediated inhibition of ductal budding by transforming growth factor-beta 1. Dev. Biol. 152:354-362.
28. E. A. Harrington, A. Fanidi, and G. I. Evan (1994). Oncogenes and cell death. [Review]. Curr. Opin. Gene. Dev. 4:120-129.
29. J. C. Reed (1994). Bcl-2 and the regulation of programmed cell death. [Review]. J. Cell Biol. 124:1-6.
30. S. J. Korsmeyer, J. R. Shutter, D. J. Veis, D. E. Merry, and Z. N. Oltvai (1993). Bcl-2/Bax: A rheostat that regulates an anti-oxidant pathway and cell death. [Review]. Sem. Cancer Biol. 4:327-332.
31. M. Li, J. Hu, K. Heermeier, L. Henninghausen, and P. Furth (1996). Apoptosis and remoldeling of mammary gland tissue during involution proceeds through p53-independent pathways. Cell Growth Differ. 7:13-20.
32. L. A. Donehower, M. Harvey, B. L. Slagle, M. J. McArthur, C. A. J. Montgomery, J. S. Butel, and A. Bradley (1992). Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature 356:215-221.
33. G. B. Silberstein and C. W. Daniel (1982). Glycosaminoglycans in the basal lamina and extracellular matrix of the developing mouse mammary duct. Dev. Biol. 90:215-222.
34. P. J. Keely, J. E. Wu, and S. A. Santoro (1995). The spatial and temporal expression of the alpha 2 beta 1 integrin and its ligands, collagen I, collagen IV, and laminin, suggest important roles in mouse mammary morphogenesis. Differentiation 59: 1-13.
35. Z. Zhang, K. Vuori, J. C. Reed, and E. Ruoslahti (1995). The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc. Natl. Acad. Sci. U.S.A. 92:6161-6165.
36. S. M. Frisch and H. Francis (1994). Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124: 619-626.
37. N. Boudreau, C. J. Sympson, Z. Werb, and M. J. Bissell (1995). Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 267:891-893.
38. R. Khokha, D. C. Martin, and J. E. Fata (1995). Utilization of transgenic mice in the study of matrix degrading proteinases and their inhibitors. [Review]. Cancer Metastasis Rev. 14: 97-111.
39. J. P. Witty, J. H. Wright, and L. M. Matrisian (1995). Matrix metalloproteinases are expressed during ductal and alveolar. Mol. Biol. Cell 6:1287-1303.
40. E. Coucouvanis and G. R. Martin (1995). Signals for death and survival: A two-step mechanism for cavitation in the vertebrate embryo. Cell 83:279-287.
41. C. W. Daniel, P. Strickland, and Y. Friedmann (1995). Expression and functional role of E- and P-cadherins in mouse mammary ductal morphogenesis and growth. Dev. Biol. 169: 511-519.
42. J. Russo and I. H. Russo (1978). DNA labeling index and structure of the rat mammary gland as determinants of its susceptibility to carcinogenesis. J. Natl. Cancer Inst. 61: 1451-1459.
43. J. Russo, G. Wilgus, and I. H. Russo (1979). Susceptibility of the mammary gland to carcinogenesis: I Differentiation of the mammary gland as determinant of tumor incidence and type of lesion. Am. J. Path. 96:721-736.
44. J. Russo and I. H. Russo (1987). Biological and molecular bases of mammary carcinogenesis. [Review]. Lab. Invest. 57: 112-137.
45. K. T. Christov, R. C. Guzman, S. M. Swanson, G. Thordarson, F. Talamantes, and S. Nandi (1996). Cell proliferation and apoptosis during mammary carcinogenesis in pituitary isografted mice. Carcinogenesis 17:1741-1746.
46. G. I. Evan, L. Brown, M. Whyte, and E. Harrington (1995). Apoptosis and the cell cycle. [Review]. Curr. Opin. Cell Biol. 7:825-834.